At this stage, any interference with the production and/or accumulation of AβPP-derived iAβ would have no effect whatsoever on the progression of AD because the disease is driven by iAβ produced in the AβPP-independent pathway [1,2,3,4,5,6]. This evidence concerns the gene APP and Alzheimer disease.